Related Experiment Videos
Desensitization in the management of vancomycin hypersensitivity
1Department of Medicine, Metropolitan Hospital-New York Medical Center, NY.
Archives of Internal Medicine
|October 1, 1990
Summary
This study details a successful desensitization protocol for a patient experiencing Red-Man Syndrome, a vancomycin hypersensitivity reaction. This method enabled safe administration of therapeutic vancomycin doses in a refractory case.
Area of Science:
- Pharmacology
- Clinical Medicine
- Immunology
Background:
- Vancomycin is crucial for treating methicillin-resistant Staphylococcus infections.
- Red-Man Syndrome (RMS) is a known vancomycin hypersensitivity reaction linked to histamine release.
- Some RMS cases require vancomycin discontinuation, limiting treatment options.
Observation:
- A patient previously tolerated vancomycin but developed RMS upon re-administration.
- Standard dose/rate reduction and antihistamines failed to prevent RMS.
- A sequential, gradual dose escalation over several days was implemented.
Findings:
- The gradual vancomycin administration protocol successfully desensitized the patient.
- Therapeutic vancomycin doses were safely administered after desensitization.
- Pre- and post-desensitization skin prick tests showed loss of reactivity to vancomycin.
Implications:
- This desensitization strategy offers a potential solution for refractory vancomycin hypersensitivity.
- It may allow continued vancomycin therapy in patients who previously experienced RMS.
- This approach could expand treatment options for severe staphylococcal infections.